Institutional Investor Partnerships offers exclusive collaboration opportunities for large-scale investors, including pension funds, endowments, and sovereign wealth funds. Our service provides comprehensive support for portfolio management, risk assessment, and strategy planning to ensure optimal investment outcomes.
Our 'Ultra-wealthy individual' service offers elite financial management with bespoke strategies tailored specifically for high-net-worth clients. Benefit from comprehensive investment plans, tax optimization, and exclusive opportunities only available to the ultra-wealthy.
With Project Financing, businesses can access a variety of funding options tailored to their specific needs and goals. Our team of experienced financial advisors works closely with clients to ensure they receive the best possible terms and conditions, enabling them to focus on what they do best: driving growth and innovation. By means of our knowledge of the world of financial securities, capital markets, real estate and private equity we keep our focus on a positive sustainable future, aiming to minimise pollution, promoting multi-national cooperation, life, innovation and GDP growth.
KEY INFORMATION NOTICE Purpose This document provides you with key information about this investment product. It is not promotional material. Providing this information is required by law to help you understand the nature, risks, costs, potential returns, and losses associated with this product and to compare it with other products. Product Product name: GCBG1 (hereinafter referred to as the "Product") Product creator: Bereshit Group osoba rizikového kapitálu a.s., Company ID 197 39 559, with its registered office at Československé armády 371/11, Prague 6, Bubeneč, 160 00 Prague 6, registered in the Commercial Register of the City Court in Prague, Section B, File 28377 (hereinafter referred to as the "Manager") Manager's website: gignatcapital.com For further information, call: +420739016582, +352691732851 or email: gignatcapital@gmail.com, alena.levi@gignatcapital.com Relevant supervisory authority: The Manager is not subject to any supervisory authority. The Manager is registered in the list of entities conducting asset management comparable to portfolio management under Section 15(1) of the ZISIF, maintained by the Czech National Bank (Na Příkopě 28, 115 03 Prague 1, www.cnb.cz). What product is this? Type Asset management gathered from investors for the purpose of collective investment based on a defined investment strategy for the benefit of these investors. Objectives Investments will be used in the following proportions: E. Fund of funds up to 100%, with special provisions F. Acquisition and holding of private equity assets (company shares) worldwide up to 40% G. Real Estate up to 40% H. Investments in securities, bonds, derivatives, loans, and mezzanine financing up to 100% The primary goal is to achieve the highest possible return for investors over a period of at least five years and six months, while minimizing risk during the execution of the project, ensuring that at least the invested capital is returned. Fund Currency EUR Main asset categories Fund of funds, Company shares – private equity, securities, bonds, loans, derivatives Industrial, geographical, and market sectors and specific asset classes Geographical focus will be global. Mixed sector strategy. Investments will be made in the following assets: Fund of funds, Company shares – private equity, securities, bonds, loans, derivatives No index will be followed. Recommended investment horizon is at least 10 years, but no less than 5.5 years. Intended Investor The product is primarily intended for (a) individuals who are legally recognized as qualified investors; (b) individuals who are likely to invest more than the equivalent of EUR 125,000 and who are expected to understand the risks. The minimum investment is EUR 125,000. This investment is not suitable for investors with a horizon shorter than 5.5 years or for investors without sufficient capital to ensure that any potential investment failure does not significantly affect their standard of living or financial goals. Duration of the product The Manager's activity is not time-limited. The investment management agreement between the investor and the Manager is for 5.5 years, with automatic extension for an indefinite period. The agreement can be terminated unilaterally after 5.5 years with a 6-month notice period, except in cases of disagreement with changes in the terms and conditions of the Manager. The investment horizon is set at 10 years, at a minimum of 5.5 years. What risks do I face and what returns might I achieve? Summary risk indicator This risk indicator assumes that you hold the product for 10 years. It is a guide to the risk level of this product compared to other products. It shows how likely the product is to lose money due to market movements or other factors. The product has been classified in risk category 2 out of 7, which is a medium-risk category. This reflects the potential losses from future performance at a level of [1= "very low" / 2= "low" / 3= "medium low" / 4= "medium" / 5= "medium high" / 6= "high" / 7= "very high"], and it is [1, 2 = "very unlikely" / 3 = "unlikely" / 4 = "possible" / 5 = "likely" / 6 = "very likely"] that the product's performance will be affected by unfavorable market conditions. The value of the product may rise and fall significantly – the risk associated with the investment can differ greatly depending on the holding period. If the investment horizon is not adhered to, you may receive substantially less. The value of the investment can fluctuate, and investment returns are not guaranteed. In extreme cases, the maximum loss could be the entire invested amount. The product does not provide any capital protection against potential market risks. The summary risk indicator does not include the following additional risks related to the investment in the Product: Operational risk, arising from potential shortcomings or failures in internal processes, human factors, or external events. Settlement risk, representing the theoretical possibility that a transaction may not settle as expected, e.g., due to non-performance by the counterparty. Performance Scenarios This table shows how much you could get back over the next 10 years under different scenarios, assuming you invest a lump sum of EUR 125,000. These scenarios illustrate how your investment might perform. You can compare them with the scenarios of other products, and they are shown before fees and do not account for any issued preferential shares for the investor. The presented scenarios are estimates based on past evidence of how the value of this investment varies, and they are not a precise indicator. The amount you get back will depend on market performance and how long you hold the product. The stress scenario shows what you could get back under exceptional market conditions and does not account for situations where we are unable to pay you. The amounts shown include all the product's costs. The figures do not take into account your personal tax situation, which could also affect how much you get back. Investment of EUR 125,000 Scenarios 10 years (Recommended holding period) Stress scenario: What you could get back after fees: EUR 125,000 (0% average annual return) Adverse scenario: What you could get back after fees: EUR 200,000 (6% average annual return) Moderate scenario: What you could get back before fees: EUR 264,500 (11.6% average annual return) Favorable scenario: What you could get back before fees: EUR 400,875 (20.7% average annual return) What happens if the Manager is unable to make a payout? The parts of the return on investment, its portions, and returns from investments that are not guaranteed by third parties will not be protected for the benefit of investors. For secured parts of investments, guarantees and securities will apply as specified in the relevant documentation. The Manager will take steps to ensure that at least 60% of the portfolio is secured in such a way that the investor will recover at least part of their initial investment. What costs are associated with the investment? The reduction in yield indicator (RIY) shows the impact of the costs associated with the investment on the returns you might receive. The total costs account for one-off, ongoing, and incidental costs. The amounts shown are cumulative costs of the product over three different holding periods. They include possible early exit fees. The data assumes a one-time investment of EUR 125,000. These figures are estimates and may change in the future. The person selling or advising you about this product may charge other costs. If so, they will inform you about these costs and explain the impact they may have on your investment over time. Investment costs over time One-time investment: EUR 125,000 Cost Breakdown The table below shows: The expected impact of different types of costs on the returns you might get at the end of the recommended holding period. The significance of different categories of costs. This table shows the impact on returns annually: One-time costs: Entry costs: 0% (Impact of costs paid when entering the investment. This is based on the maximum entry fee, which is set by the product distributor.) Exit costs: 0% (Impact of costs when exiting the investment after the recommended holding period.) Ongoing costs: Portfolio transaction costs: 0.16% (Impact of our purchases and sales of underlying assets on the product.) Other ongoing costs: 0.04% (Impact of costs incurred each year for managing your investments.) Incidental costs: Performance fees: 10% (Impact of performance fees taken from the net appreciation of your investment, if the product performs positively, only for certain private equity investments.) Capital appreciation rewards: 0% (Impact of rewards for capital appreciation.) How long should I hold the investment? Can I withdraw my money early? Recommended holding period: 10 years. The length of the recommended horizon is related to the product's risk profile, as riskier assets are subject to higher market fluctuations over shorter periods, which can negatively impact the value of the investment. Adhering to the horizon significantly increases the likelihood of a positive return on the investment. Your investment in the Product is made for at least 5.5 years, with automatic extension for an indefinite period and the possibility of unilateral termination after 5.5 years with a 6-month notice period, except in cases where the Client does not accept unilateral changes in the terms and conditions. How can I file a complaint? You have the option to submit a complaint or grievance in the following ways: a) By email at: gignatcapital@gmail.com; alena.levi@gignatcapital.com b) By mail to: Bereshit Group Venture Capital Inc., Československé armády 371/11, Prague 6, 160 00. The Manager aims to resolve any complaint or grievance satisfactorily. Complaints or grievances should be submitted without undue delay from the moment the investor becomes aware of the reasons for submission, to allow timely investigation and assessment. The investor must include identification details; for flexible resolution, providing a phone number and email is also recommended. Additionally, the complaint should describe the issue and include all relevant documentation. Other relevant information Documents the investor (client) is entitled to by law: contractual materials, key information notice. Documents/information available beyond the legal requirement, which are available to the investor – these can be obtained upon request: Any other information related to your contract. Additional information can be obtained through the website www.gignatcapital.com, by phone, or in writing through the contact details in the "Basic Information about the Product" section. This Key Information Notice has been prepared in accordance with the European Parliament and Council Regulation (EU) No. 1286/2014/EU and will be updated and reviewed at least every 12 months. The current version of the key information notice is available at the Manager’s office and is provided to anyone interested in investing in the Product. Date of preparation of key information: December 14, 2024.